Mizuho Maintains Outperform on IDEAYA Biosciences, Lowers Price Target to $39

Benzinga · 5d ago
Mizuho analyst Graig Suvannavejh maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target from $44 to $39.